Literature DB >> 10372123

Characterization of purified and ex vivo manipulated human hematopoietic progenitor and stem cells in xenograft recipients.

T A Bock1, B L Ziegler, H J Bühring, S Scheding, W Brugger, L Kanz.   

Abstract

Research on the biology, regulation, and transplantation of human hematopoietic stem cells requires test systems for the detection, monitoring, and quantitation of these cells. Xenografted animal models provide suitable stem cell assays, since they allow long-term engraftment, multilineage differentiation, and serial transfer of human hematopoietic cells. Recent techniques for the separation of hematopoietic cells have provided highly purified cellular subsets selected on the basis of the surface marker phenotype. The stem cell content of these subsets, however, is still unclear. Also, innovative approaches for the induction of hematopoietic cell proliferation and differentiation have generated ex vivo manipulated cells whose biological properties and functions still remain to be assessed. This paper reports on the biological characterization of these cell populations by the use of xenograft models.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10372123     DOI: 10.1111/j.1749-6632.1999.tb08465.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  2 in total

1.  Effect of testosterone and hypoxia on the expansion of umbilical cord blood CD34+ cells in vitro.

Authors:  Liping Zhou; Xiaowei Zhang; Panpan Zhou; Xue Li; Xuejing Xu; Qing Shi; Dong Li; Xiuli Ju
Journal:  Exp Ther Med       Date:  2017-08-24       Impact factor: 2.447

2.  Cryopreservation of neurospheres derived from human glioblastoma multiforme.

Authors:  Yuk-Kien Chong; Tan-Boon Toh; Norazean Zaiden; Anuradha Poonepalli; Siew Hong Leong; Catherine Ee Ling Ong; Yiting Yu; Patrick B Tan; Siew-Ju See; Wai-Hoe Ng; Ivan Ng; Manoor P Hande; Oi Lian Kon; Beng-Ti Ang; Carol Tang
Journal:  Stem Cells       Date:  2009-01       Impact factor: 6.277

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.